Organ Preservation Market | Global Sales Analysis Report - 2032
In a groundbreaking revelation, the Global Organ Preservation Industry is poised for remarkable expansion, projecting a staggering value of US$ 455 million by the year 2032. This ambitious forecast is underpinned by an impressive Compound Annual Growth Rate (CAGR) of 6.4%, according to a comprehensive report by Future Market Insights Inc.
The field of organ preservation plays a pivotal role in securing the viability of healthy donor organs, ensuring their successful transplantation into recipients. Organ transplantation stands as a transformative medical breakthrough, offering hope and extended life to countless patients worldwide. However, the key to the success of these procedures lies in the meticulous preservation of donor organs.
One of the emerging and crucial technologies in organ preservation is static cold storage (SCS). This method proves to be instrumental in safeguarding the health of donor organs by preventing toxic metabolites from causing damage to the tissues. SCS facilitates the preservation of normal organ function post-transplantation, significantly enhancing the overall success rates of transplant procedures.
Global Organ Preservation Industry Overview:
The act of keeping healthy organs after they have been removed from donors’ bodies is known as organ preservation. Without causing much harm, organs are removed from the donor’s body, transported, and then transplanted into the body of the recipient. The results of this study indicate that the adoption of organ preservation is directly impacted by the increased prevalence of chronic illnesses.
Request a Sample of this Report Now!
https://www.futuremarketinsigh....ts.com/reports/sampl
Organ preservation for transplantation has a strong influence on donor organ quality, which has a direct impact on a patient’s morbidity and survival rates following transplantation. One of the major factors driving the growth of the organ preservation solutions market is the increasing prevalence of chronic illnesses, as well as the world’s growing elderly population.
Because of the increasing number of organ failures caused by diabetes, cardiovascular diseases (CVDs), obesity, and other serious medical problems, static cold storage organ preservation treatments are becoming more common. Innovative and sophisticated organ preservation strategies, such as NMP, act as a growth-inducing agent.
In clinical and experimental research, such strategies help to reduce the risk of reperfusion damage after transplantation and improve static cold storage organ preservation results. Furthermore, an increasing number of government and non-government regulations and activities to encourage organ donation are positively impacting the growth of the organ preservation solutions market.
The growing number of people who volunteer to donate their organs for transplantation and research is also propelling the market forward. Other factors, such as increased R&D and significant developments in the Global Organ Preservation Industry, are expected to significantly contribute to market expansion.
Global Organ Preservation Industry Key Takeaways:
A preservation injury occurs when the liver no longer functions. A liver transplant, also known as a hepatic transplant, has the potential to save someone’s life. A liver transplant may also be recommended by a doctor to a patient who has reached the end stage of liver disease.
Individuals who received a liver transplant had an 89% chance of survival after one year, according to an article published in the American Journal of Transplantation. The growing need for organ transplantation is propelling the Global Organ Preservation Industry across the board.
According to the American Transplant Foundation, approximately 114,000 people in the United States are currently on the waiting list for a life-saving organ transplant. Every day, on average, 20 people die due to a lack of available organs for transplantation.
Competition Analysis:
The Global Organ Preservation Industry is dominated by companies such as Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut (Netherlands).
Key Segments Covered in the Global Organ Preservation Industry Study:
By Solution:
University of Wisconsin Solution (UW Solution)
Custodial HTK
Perfadex
Other Solutions
By Technique:
Static Cold Storage
Hypothermia Machine Perfusion
Normothermic Machine Perfusion
By Organ Type:
Kidney
Liver
Long
Heart
Pancreas
By End User:
Organ Transplant Centres
Hospitals
Specialty Clinics
1 (877) 773-1002